Literature DB >> 8412625

Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.

U Vogel1, I B Autenrieth, R Berner, J Heesemann.   

Abstract

In the present study the role of Yersinia enterocolitica antigens in humoral immunity against secondary Y. enterocolitica infection has been investigated. For this purpose, BALB/c mice, 4 weeks after immunization by primary infection with a sublethal dose of various Y. enterocolitica strains and mutant strains, were challenged with a lethal dose of highly virulent Y. enterocolitica strains of serotype O:8. As evident from the survival rate and protection against bacterial growth in the spleens of mice, only immunization with wild-type or attenuated strains harbouring an intact virulence plasmid mediated protection against a lethal challenge. Protection by immunization with plasmid-harbouring strains correlated with persistence of the bacteria in spleens for at least 7 days after immunization and high serum titres of Yersinia-specific antibodies directed against both chromosomal and plasmid-encoded determinants. Furthermore, the adoptive transfer of the purified IgG fraction of a rabbit serum specific for the adhesin YadA encoded by virulence plasmid pO8 from Y. enterocolitica O:8 mediated protection against a lethal challenge with the serotype O:8 strain harbouring the virulence plasmid pO8 but did not mediate protection when this strain harboured the virulence plasmid pO9 from serotype O:9. In summary, the results demonstrate that in our experimental mouse infection model: (i) the presence of the intact virulence plasmid in an immunizing Y. enterocolitica strain is essential for induction of protection against a lethal challenge with highly virulent Y. enterocolitica and (ii) that antibodies against plasmid-encoded determinants of Y. enterocolitica, especially YadA, are of major importance for achievement of protective immunity in mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412625     DOI: 10.1006/mpat.1993.1054

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  16 in total

1.  Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils.

Authors:  A Roggenkamp; K Ruckdeschel; L Leitritz; R Schmitt; J Heesemann
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.

Authors:  Holger Rüssmann; Klaus Panthel; Brigitte Köhn; Stefan Jellbauer; Sebastian E Winter; Sara Garbom; Hans Wolf-Watz; Sigrid Hoffmann; Silke Grauling-Halama; Gernot Geginat
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

3.  Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.

Authors:  G Kingsley; J Sieper
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

4.  Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica.

Authors:  E I Igwe; H Rüssmann; A Roggenkamp; A Noll; I B Autenrieth; J Heesemann
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA.

Authors:  C Elkins; K J Morrow; B Olsen
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon.

Authors:  I B Autenrieth; M Beer; E Bohn; S H Kaufmann; J Heesemann
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils.

Authors:  K Ruckdeschel; A Roggenkamp; S Schubert; J Heesemann
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Duration of carriage and transmission of Yersinia enterocolitica biotype 4, serotype 0:3 in dogs.

Authors:  S G Fenwick; P Madie; C R Wilks
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

9.  Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparations.

Authors:  I B Autenrieth; A Schwarzkopf; J H Ewald; H Karch; R Lissner
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats.

Authors:  K I Gaede; J Heesemann
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.